ACTIVE

Sartorius Xpress Biologics

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-6,5 M €-195,4 %over 1 year

Revenue2,4 M €-33,3 %over 1 year

Equity-9,5 M €-235,5 %over 1 year

Workforce76,2 ETP+6,6 %over 1 year

Identity

Source · BCE/KBO

Sartorius Xpress Biologics is a Public limited company incorporated in 2014. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Herstal. It employs on average 76,2 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0550.686.915
Incorporation: 16/04/2014
Legal form: Public limited company
Registered office: Avenue du Parc Industriel 89
4041 Herstal · WallonieSee on map
Contributed capital: 4 545 739,00 €
Latest accounts: 31/12/2025
Average workforce: 76,2 ETP

Activities (NACE)

21100Manufacture of basic pharmaceutical products· main 21100Manufacture of basic pharmaceutical products 72101Research and experimental development on natural sciences and engineering 72110Research and experimental development on biotechnology 21100Manufacture of basic pharmaceutical products 21100Manufacture of basic pharmaceutical products+6

Joint committees (1)

Signals

Healthy social debtsHigh revenue

Financials

Source · NBB, 12 filings

Trend over 12 financial years

	2025		2024		2023		2022		2021
Income statement
Revenue	2,4 M €	-33.3%	3,6 M €	+94.7%	1,9 M €	+83.6%	1 M €	-59.2%	2,5 M €
EBITDA	-4,7 M €	-712%	-580,6 k €	+80.4%	-3 M €	-1377%	-200,3 k €	-143%	461,7 k €
Operating result	-6,2 M €	-205%	-2 M €	+53.4%	-4,4 M €	-335%	-1 M €	-1005%	-91,3 k €
Net result	-6,5 M €	-195%	-2,2 M €	+47.1%	-4,2 M €	-378%	-870,1 k €	-1557%	59,7 k €
Balance sheet
Equity	-9,5 M €	-235%	-2,8 M €	-486%	-482,3 k €	-272%	279,8 k €	-76.7%	1,2 M €
Total assets	10,9 M €	-6.3%	11,7 M €	+15.3%	10,1 M €	+10.6%	9,1 M €	+104%	4,5 M €
Cash	0 €	-100%	177,3 k €	-60.6%	449,7 k €	+222%	139,6 k €	-78.4%	646,6 k €
Debts	20,4 M €	+40.8%	14,5 M €	+36.7%	10,6 M €	+19.6%	8,9 M €	+170%	3,3 M €
Other
Workforce	76,2 ETP	+6.6%	71,5 ETP	+15.0%	62,2 ETP	+65.0%	37,7 ETP	+84.8%	20,4 ETP

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 26 ended

Active mandates

Cédric VOLANTI

Director · since 01 décembre 2025 · until 30 novembre 2031

Active

Franck BACKERS

Managing director · since 01 avril 2024 · until 31 mars 2030

Active

Jonas Skjødt MOLLER

Director · since 01 avril 2024 · until 01 décembre 2025

Active

Ended mandates

Jonas Skjødt MOLLER

Director · since 01 avril 2024 · until 31 mars 2030

Ended

MDT SERVICES & TECHNOLOGIES

Managing director · since 30 mars 2023 · until 01 avril 2024 · 0544.556.812

Represented by Marc DAUKANDT

Ended

MDT SERVICES & TECHNOLOGIES

Managing director · since 30 mars 2023 · until 29 mars 2029 · 0544.556.812

Represented by Marc DAUKANDT

Ended

MPH

Managing director · since 02 décembre 2022 · until 01 avril 2024 · 0716.966.986

Represented by Mario PHILIPS

Ended

Other companies at this address

Avenue du Parc Industriel 89 4041 Herstal

Company	CBE no.
Sartorius Accessia Pharma● Active	0650.670.852
XpressBioX● Active	0770.527.814

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/07/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	6 months
Filing date	13/04/2026	09/04/2025	29/05/2024	26/05/2023	06/07/2022	09/07/2021
General meeting	26/03/2026	27/03/2025	16/05/2024	19/05/2023	20/06/2022	20/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 12 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	26/03/2026	13/04/2026	French	PDF
Full model	31/12/2024	27/03/2025	09/04/2025	French	PDF
Full model	31/12/2023	16/05/2024	29/05/2024	French	PDF
Abridged model	31/12/2022	19/05/2023	26/05/2023	French	PDF
Abridged model	31/12/2021	20/06/2022	06/07/2022	French	PDF
Abridged model	31/12/2020	20/05/2021	09/07/2021	French	PDF
Abridged model	30/06/2020	26/11/2020	29/01/2021	French	PDF
Abridged model	30/06/2019	19/12/2019	30/01/2020	French	PDF
Abridged model	30/06/2018	14/12/2018	16/01/2019	French	PDF
Abridged model	30/06/2017	16/11/2017	05/12/2017	French	PDF
Abridged model	30/06/2016	14/11/2016	16/12/2016	French	PDF
Abridged model	30/06/2015	17/11/2015	16/12/2015	French	PDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 26 ended

Active mandates

Cédric VOLANTI

Director · since 01 décembre 2025 · until 30 novembre 2031

Active

Franck BACKERS

Managing director · since 01 avril 2024 · until 31 mars 2030

Active

Jonas Skjødt MOLLER

Director · since 01 avril 2024 · until 01 décembre 2025

Active

Ended mandates

Jonas Skjødt MOLLER

Director · since 01 avril 2024 · until 31 mars 2030

Ended

MDT SERVICES & TECHNOLOGIES

Managing director · since 30 mars 2023 · until 01 avril 2024 · 0544.556.812

Represented by Marc DAUKANDT

Ended

MDT SERVICES & TECHNOLOGIES

Managing director · since 30 mars 2023 · until 29 mars 2029 · 0544.556.812

Represented by Marc DAUKANDT

Ended

MPH

Managing director · since 02 décembre 2022 · until 01 avril 2024 · 0716.966.986

Represented by Mario PHILIPS

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates28/01/2025
DENOMINATION - ASSEMBLEE GENERALE
PDF
Mandates25/04/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates04/04/2023
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
PDF
Mandates30/12/2022
DEMISSIONS, NOMINATIONS
PDF
Mandates12/07/2022
DEMISSIONS, NOMINATIONS
PDF
Mandates03/05/2022
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - DEMISSIONS, NOMINATIONS
PDF
Mandates05/11/2021
DEMISSIONS, NOMINATIONS
PDF
Mandates22/09/2021
CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 2025-6,5 M €↓
2024
Annual accounts 2024-2,2 M €↑
2024
Name changeSartorius Xpress Biologics
2023
Annual accounts 2023-4,2 M €↓
2022
Annual accounts 2022-870,1 k €↓
2021
Annual accounts 202159,7 k €↑
2021
Name changeXPRESS BIOLOGICS
2020
Annual accounts 2020-156,3 k €↑
2020
Annual accounts 2020-367,5 k €↓
2019
Annual accounts 201914,1 k €↑
2018
Annual accounts 2018-648,6 k €↓
2017
Annual accounts 201763,5 k €↑
2016
Annual accounts 2016-344,4 k €↑
2015
Annual accounts 2015-421,7 k €
16/04/2014
IncorporationPublic limited company

Sartorius Xpress Biologics

Overview

Identity

Financials

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline